Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
cetirizine hydrochloride, Quantity: 10 mg
Medreich Australia Pty Ltd
Tablet, film coated
Excipient Ingredients: calcium hydrogen phosphate; hypromellose; colloidal anhydrous silica; lactose monohydrate; purified water; sodium starch glycollate type A; maize starch; titanium dioxide; purified talc; povidone; magnesium stearate; propylene glycol
Oral
100 tablets, 30 tablets, 10 tablets, 70 tablets
(S2) Pharmacy Medicine
Seasonal Allergic Rhinitis: Cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children 6 years and over. Symptoms treated effectively include sneezing, rhinorrhea, post-nasal discharge, nasal pruritus, ocular pruritus, tearing and redness of the eyes., Perennial allergic rhinitis: Cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 years and over. Symptoms treated effectively include sneezing, rhinorrhea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing., Chronic idiopathic urticaria: Cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years and over. It significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. As with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.
Visual Identification: White, capsule shaped film coated tablets with breakline on one side and "M+" embossed on other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2018-07-09